FERTILITY SUPPLEMENTS: MAKING THE RIGHT CHOICE
Navigating the supplement maze: Unveiling the truth
Choosing a preconceptual or prenatal supplement can feel like a daunting task. Tablets, capsules, softgels, powders, gummies—how do you decide? Some products use herbal extracts, unconventional ingredients, or alluring packaging, while others make unverified claims of benefits. Such tactics are used by companies to catch your attention and stand out from the rest.
The unregulated nature of food supplements means that anyone, from celebrities to moms, students, and even doctors, can market a product. In the US alone, this has led to an explosion of about 200 fertility products, all claiming to be safe and beneficial. But are they, and how do you make an informed choice? Let's delve into the facts:
- Most prenatal and preconceptual supplements use different ingredients, or varying doses of the same ingredients, so they cannot all provide the same benefits.
- Many supplements use excessive doses of at least one ingredient, raising safety concerns, while others only use cosmetic doses that are ineffective.
- Most products are ‘one-size-fits all’, assuming your age and fertility potential don't impact your nutritional requirements. For instance, both a 25- and 40-year old pregnant woman are recommended the same prenatal.
- The majority of supplements are not research-backed and/or fail to substantiate their claims with credible, published, peer-reviewed scientific evidence.
- Doctors rarely recommend the same supplements, primarily due to the lack of robust scientific evidence supporting their effectiveness in improving fertility.
Setting new standards for fertility supplements
Committed to scientific rigor, we apply pharmaceutical R&D standards to develop all our supplements, providing you with evidence-backed products you can trust on your journey to parenthood.
Knowledge is power – get to know us and make your choice an informed one.
Meet Our Visionaries: Pioneers in Reproductive Biology
Professor John Aitken and Dr. Parviz Gharagozloo, our founders, bring a wealth of experience in the fields of reproductive biology and therapeutics, collectively spanning over five decades. Their profound insights have played a crucial role in advancing our understanding of human reproductive health.
Their collaboration began over 25 years ago in the United Kingdom, where they served as department heads at the Medical Research Council (MRC). The MRC is a government organization responsible for overseeing funding of all academic medical research nationwide.
Today, they both continue pioneering research programs at various academic institutions, hospitals, and within industry. They are focused on unraveling the factors contributing to the worldwide silent pandemic of declining fertility, believed to be significantly influenced by modern lifestyles and environmental factors.
Real science, not hype
Consumer skepticism around supplements is warranted, given the industry's lack of regulation. But Fertilix stands apart.
- Our commitment is to provide the most effective, rigorously tested, highest quality, and personalized supplements to aspiring parents.
- We adhere to pharmaceutical standards and practices of R&D, supported by a decade of groundbreaking research that's been peer-reviewed and published in top-tier scientific journals.
- We’re firmly committed to continuously advancing the field through ongoing preclinical and clinical research studies, ensuring that our products always reflect the latest scientific discoveries.
For a deeper look into our expertise, meet our founders and explore our global scientific advisory board below.
John Aitken, PhD, ScD, FRSE, FRSN, FAHMS, FAA
Chief Scientific Officer | AUSTRALIA
John Aitken’s research career began with a PhD in reproductive biology from the University of Cambridge. Now a Distinguished Emeritus Laureate Professor of Biological Sciences at the University of Newcastle, Australia and serving on the editorial boards of 8 scientific journals, his contributions to the field are unmatched. A scientist’s ‘h-index’ is an estimate of the importance, significance, and broad impact of their cumulative research contributions: 20 is good, 40 is outstanding, and 60 is truly exceptional. Professor Aitken’s h-index is 130. He has been elected a Fellow of both the Royal Society of Edinburgh and the Australian Academy of Science, was named as the 2012 New South Wales Scientist-of-the-Year, and 2016 recipient of the prestigious Carl G Hartman award.
Parviz Gharagozloo, PhD
President & CEO | USA & UK
Parviz Gharagozloo has over 30 years of experience in academia, biotechnology, and pharmaceutical companies in the UK and USA. He has published extensively in the fields of organic and medicinal chemistry, and his work is recognized by a number of international patents, including Fertilix. Dr. Ghargozloo's last academic post was the head of Medicinal Chemistry at Medical Research Council (MRC) Technology Center in London. He and Professor Aitken’s landmark publication on oxidative stress and antioxidant therapy is recognized as the most highly cited article in the field.
Scientific Advisory Team
Joël Drevet, PhD
Honorary Scientific Advisor | FRANCE
Joël Drevet’s research focuses on sperm maturation and the impact of oxidative stress on fertility, both in natural reproduction and in assisted reproductive technologies (ART). Professor Drevet has an h-index of 45 and is a member of the European Academy of Andrology (EAA), the European Society of Human Reproduction and Embryo (ESHRE), and the North American Society for Studies on Reproduction (SSR). Joël is managing editor of the journal of the French Andrology Society, Basic & Clinical Andrology (BaCA), associate editor of the Asian Journal of Andrology, academic editor of Oxidative Medicine & Cellular Longevity, associate editor of Antioxidants, and academic editor of PLoS ONE. In addition, Joël is currently a member of the review board of Andrology.
Jorge Hallak, MD, PhD
Honorary Medical/Scientific Advisor | BRAZIL
Jorge Hallak is a practicing urologist, Associate Professor of Medicine, and serves as the Coordinator of the Reproductive Toxicology Unit at the University of Sao Paulo Medical School. He is also the Technical and Scientific Director at Androscience – Science and Innovation Center in Andrology in Sao Paulo. Professor Hallak has an h-index of 36 and actively contributes to various international medical associations, such as the American Society of Andrology, American Urological Association, American Society for Reproductive Medicine, Society for the Study of Male Reproduction, International Society of Urology, and the International Society for the Study of the Aging Male.
Alfonso Gutiérrez-Adán, PhD
Honorary Scientific Advisor | SPAIN
Alfonso Gutiérrez-Adán obtained his PhD in Biological Sciences from the University of Oviedo in Spain and completed his postdoctoral studies at the University of Davis, CA. He returned to the University of Madrid and currently serves as INIA department director and head of the “Gametogenesis, embryo development and mRNA splicing” lab. Professor Gutiérrez-Adán has an h-index of 61 and the primary focus of his research team is on the molecular processes that occur during the early stages of fertilization and embryo development.
Our scientific team is world-renowned
With a track record featuring over 800 peer-reviewed publications and 60 book chapters, our distinguished scientists in the field of human reproduction are dedicated to unraveling the impact of long-term nutrient deficiency and cellular redox stress—both associated with fertility decline and various reproductive challenges. Their expertise in nutrient biochemistry and reproductive health has led to the development of the most advanced line of fertility supplements, FERTILIX, to support all couples before, during, and after pregnancy.